Skip to search.
 FTSE 100 Down 0.67%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
9.97 Down 0.19(1.87%) 2 Jul 21:00
Add to Portfolio
Prev Close:10.16
Open:10.20
Bid:9.74 x 100
Ask:11.10 x 500
1y Target Est:22.00
Beta:2.97
Earnings Date:21 Jul - 27 Jul (Est.)
Day's Range:9.88 - 10.31
52wk Range:9.39 - 19.25
Volume:762,071
Avg Vol (3m):844,175
Market Cap:693.74m
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGMODown 1.87%693.74m
AMGNDown 1.12%116.53b
LLYUp 1.52%91.22b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback